Among the remaining genes, SOD2 was significantly upregulated upon interaction of CD44 with its major ligand hyaluronan (HA), suggesting that SOD2 might be an additional novel transcriptional target of CD44-downstream signaling that underpins its role in promoting BC tumor cell invasion and metastasis. The gene discussed is SOD2; the disease is breast cancer.